Level Biotechnology Operating Margin vs. Return On Asset
| 3118 Stock | TWD 32.65 0.30 0.93% |
For Level Biotechnology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Level Biotechnology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Level Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Level Biotechnology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Level Biotechnology over time as well as its relative position and ranking within its peers.
Level |
Level Biotechnology Return On Asset vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Level Biotechnology's current stock value. Our valuation model uses many indicators to compare Level Biotechnology value to that of its competitors to determine the firm's financial worth. Level Biotechnology is number one stock in operating margin category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.47 of Return On Asset per Operating Margin. The ratio of Operating Margin to Return On Asset for Level Biotechnology is roughly 2.11 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Level Biotechnology's earnings, one of the primary drivers of an investment's value.Level Return On Asset vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Level Biotechnology |
| = | 0.11 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Level Biotechnology |
| = | 0.0519 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Level Return On Asset Comparison
Level Biotechnology is currently under evaluation in return on asset category among its peers.
Level Biotechnology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Level Biotechnology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Level Biotechnology will eventually generate negative long term returns. The profitability progress is the general direction of Level Biotechnology's change in net profit over the period of time. It can combine multiple indicators of Level Biotechnology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Level Biotechnology Inc. markets and distributes cell culture, immunology, molecular biology products and biomedical precision equipment in Taiwan. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan. LEVEL BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 122 people.
Level Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Level Biotechnology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Level Biotechnology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Level Biotechnology's important profitability drivers and their relationship over time.
Use Level Biotechnology in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Level Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Level Biotechnology will appreciate offsetting losses from the drop in the long position's value.Level Biotechnology Pair Trading
Level Biotechnology Pair Trading Analysis
The ability to find closely correlated positions to Level Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Level Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Level Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Level Biotechnology to buy it.
The correlation of Level Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Level Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Level Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Level Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Level Biotechnology position
In addition to having Level Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Level Stock Analysis
When running Level Biotechnology's price analysis, check to measure Level Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Level Biotechnology is operating at the current time. Most of Level Biotechnology's value examination focuses on studying past and present price action to predict the probability of Level Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Level Biotechnology's price. Additionally, you may evaluate how the addition of Level Biotechnology to your portfolios can decrease your overall portfolio volatility.